| Dr David Dana De Haas, MD | |
|
9920 Talbert Ave, Fountain Valley, CA 92708-5153 | |
| (714) 378-7535 | |
| Not Available |
| Full Name | Dr David Dana De Haas |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 9920 Talbert Ave, Fountain Valley, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760593248 | NPI | - | NPPES |
| 00G525730 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G52573 (California) | Primary |
| Entity Name | Regents Of The University Of |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154379394 PECOS PAC ID: 7517869605 Enrollment ID: O20040120001119 |
News Archive
New research in the U.S. is indicating that cholesterol-lowering statin drugs may protect against the development of lung cancer.
Scientists have come up with a new discovery that could transform our understanding of how childhood growth and development are measured – the DNA clock. The study, published in the Proceedings of the National Academy of Science, is the first paper to...
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.
Results from a Polish study show that a substantial proportion of patients with major depressive disorder meet criteria for subthreshold bipolarity.
› Verified 7 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
New research in the U.S. is indicating that cholesterol-lowering statin drugs may protect against the development of lung cancer.
Scientists have come up with a new discovery that could transform our understanding of how childhood growth and development are measured – the DNA clock. The study, published in the Proceedings of the National Academy of Science, is the first paper to...
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.
Results from a Polish study show that a substantial proportion of patients with major depressive disorder meet criteria for subthreshold bipolarity.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Dana De Haas, MD 2100 Powell St, Suite 900, Emeryville, CA 94608-1826 Ph: (510) 350-2600 | Dr David Dana De Haas, MD 9920 Talbert Ave, Fountain Valley, CA 92708-5153 Ph: (714) 378-7535 |
News Archive
New research in the U.S. is indicating that cholesterol-lowering statin drugs may protect against the development of lung cancer.
Scientists have come up with a new discovery that could transform our understanding of how childhood growth and development are measured – the DNA clock. The study, published in the Proceedings of the National Academy of Science, is the first paper to...
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.
Results from a Polish study show that a substantial proportion of patients with major depressive disorder meet criteria for subthreshold bipolarity.
› Verified 7 days ago
Theresa S Maestas, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 17100 Euclid St, Fountain Valley, CA 92708 Phone: 714-966-7200 | |
Ronald J Hitzfield, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 9920 Talbert Ave, Fountain Valley, CA 92708 Phone: 714-378-7535 | |
James Pugeda, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 18111 Brookhurst St Ste 3200, Fountain Valley, CA 92708 Phone: 714-369-1100 Fax: 714-464-4645 | |
Robert C Cockrell, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 17100 Euclid, Fountain Valley, CA 92708 Phone: 714-966-7200 | |
Craig Farmer, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 17100 Euclid St, Fountain Valley, CA 92708 Phone: 714-966-7200 | |
Douglas J Anderson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 17100 Euclid, Fountain Valley, CA 92708 Phone: 714-966-7200 | |
Stephen H Morenz, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 17100 Euclid, Fountain Valley, CA 92708 Phone: 714-966-7200 |